As whooping cough cases rise in the U.S., a new nasal vaccine developed ... caused by the Bordetella pertussis bacteria. However, the vaccines fail to clear bacteria from the upper respiratory ...
As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University ... effective at preventing whooping cough, caused by the Bordetella pertussis bacteria. However, the ...
To help reduce the spread of whooping cough, researchers at Tulane University of Medicine in New Orleans developed a new ...
the leading next generation intranasal pertussis vaccine. This innovative medicine designation has been awarded to BPZE1 indicated for active immunization against both upper respiratory tract B.
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies (ILiAD), a clinical-stage biotech company dedicated to the prevention and treatment of human disease caused by Bordetella pertussis and other ...